Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lihong Ke"'
Autor:
Mengge Li, Shusheng Wu, Huiqin Luo, Jiayu Niu, Ying Yan, Yuan Fang, Lihong Ke, Wenju Chen, Huijun Xu, Huimin Li, Xiaoxiu Hu, Lulu Cao, Yaolin Chen, Hong Tu, Yifu He
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Hepatitis B virus (HBV) infection has been reported to be associated with gastric cancer (GC). Nonetheless, no study has revealed the role of HBV infection in the survival of patients with GC, and the mutation profiles of HBV-infected patients with G
Externí odkaz:
https://doaj.org/article/5515974bc66d4cf6a390f2177f98a75d
Autor:
Ying Yan, Wenju Chen, Yueyin Pan, Jiayu Niu, Hui-qin Luo, Shusheng Wu, Yifu He, Huimin Li, Huijun Xu, Lulu Cao, Xiaoxiu Hu, Lihong Ke
Publikováno v:
Journal of Cellular and Molecular Medicine
Previous studies have indicated that centromere protein K (CENPK) is upregulated in several cancers and related to tumorigenesis. Nevertheless, the potential function of CENPK in gastric cancer (GC) remains unknown. Here, we investigated the function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f64a2492f8fead96995799cc8b9e91
http://europepmc.org/articles/PMC8435434
http://europepmc.org/articles/PMC8435434
Autor:
Ying Yan, Huimin Li, Shusheng Wu, Gang Wang, Huiqin Luo, Jiayu Niu, Lulu Cao, Xiaoxiu Hu, Huijun Xu, Wei Jia, Yubei Sun, Yiwei Yao, Wenju Chen, Lihong Ke, Bing Hu, Chushu Ji, Yancai Sun, Jian Chen, Mengge Li, Yifu He
Publikováno v:
Ann Transl Med
BACKGROUND: Previous studies of the second-line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma (GC/GEJAC) had reported that apatinib combined with chemotherapy improved the treatment outcomes. However, the benefits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f6b8674650a4c0c70c5888f7789118
https://europepmc.org/articles/PMC8908117/
https://europepmc.org/articles/PMC8908117/
Autor:
Yifu He, Shusheng Wu, Conglan Ding, Liyuan Fan, Lihong Ke, Ying Yan, Mengge Li, Huiqin Luo, Xiaoxiu Hu, Jiayu Niu, Huimin Li, Huijun Xu, Wenju Chen, Lulu Cao
Publikováno v:
Journal of Clinical Oncology. 40:e16104-e16104
e16104 Background: In China, the incidence of gastric cancer and esophageal cancer ranks second and third, respectively. These patients often suffer from malnutrition, anorexia and gastroesophageal reflux, which have a serious implication on their su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2def9546e579bfaf6f7f917c9a71add
https://doi.org/10.1200/jco.2022.40.16_suppl.e16104
https://doi.org/10.1200/jco.2022.40.16_suppl.e16104
Autor:
Huimin Li, Huiqing Luo, Yifu He, Huijun Xu, Jiayu Niu, Ying Yan, Shusheng Wu, Mengge Li, Lulu Cao, Xiaoxiu Hu, Lihong Ke, Yang Yang, Wenju Chen
Publikováno v:
Medicine: Case Reports and Study Protocols. 2:e0147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::860ea7127537b665c52dfc239e089c61
https://doi.org/10.1097/md9.0000000000000147
https://doi.org/10.1097/md9.0000000000000147
Autor:
Ying Yan, Lihong Ke, Tengyun Xu, Gang Wang, Huijun Xu, Yubei Sun, Bing Hu, Shusheng Wu, Wenju Chen, Yifu He, Lulu Cao, Jiayu Niu, Chushu Ji, Hui-Qin Luo, Xiaoxiu Hu, Yancai Sun, Huimin Li, Chenxuan Liu
Publikováno v:
Journal of Clinical Oncology. 39:e16018-e16018
e16018 Background: Apatinib, a VEGFR-2 tyrosine kinase inhibitor, is wildly used for the treatment of advanced or metastatic gastric cancer. However, dose modification and interruption are happened frequently due to poor patient conditions and treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a728d1297fd1d24f0c85b98f6aef077c
https://doi.org/10.1200/jco.2021.39.15_suppl.e16018
https://doi.org/10.1200/jco.2021.39.15_suppl.e16018
Autor:
Lihong Ke, Xiaoxiu Hu, Huijun Xu, Hui-qin Luo, Yi-Fu He, Lulu Cao, Wenju Chen, Hui Li, Jiayu Niu, B. Hu, T. Xu, Yu Yan, Yi Sun, Shu‑Sheng Wu, C. Ji, G. Wang
Publikováno v:
Annals of Oncology. 30:iv22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08c87e14c9abc383f54e672ddffc22aa
https://doi.org/10.1093/annonc/mdz155.081
https://doi.org/10.1093/annonc/mdz155.081
Autor:
Yi-Fu He, Huimin Li, Wenju Chen, Jiayu Niu, Huijun Xu, Shu-Sheng Wu, Lihong Ke, Hui-qin Luo, Xiaoxiu Hu, Ying Yan
Publikováno v:
Technology in Cancer Research & Treatment
Objective: The immune makers including CD4+CD25+ T cells, natural killer cells, and T cells subgroup were retrospectively analyzed to find the relationship between apatinib and the immune system in the patients treated with apatinib. Method: Forty-tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2119a615ed88f333958d82e123d2d7dd
https://doi.org/10.1177/1533033819893667
https://doi.org/10.1177/1533033819893667
Autor:
Yi-Fu He, T. Xu, Huijun Xu, Shu‑Sheng Wu, Wenju Chen, G. Wang, B. Hu, Yu Yan, Lihong Ke, Jiayu Niu, Hui Li, Yi Sun, Lulu Cao, C. Ji, Xiaoxiu Hu, Hui-qin Luo
Publikováno v:
Annals of Oncology. 29:v26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bab70a25762b953bf12b36cbd1f8899
https://doi.org/10.1093/annonc/mdy151.094
https://doi.org/10.1093/annonc/mdy151.094